These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31744230)

  • 1. p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer.
    Smirnov A; Anemona L; Novelli F; Piro CM; Annicchiarico-Petruzzelli M; Melino G; Candi E
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases.
    Chakraborty S; Swanson BJ; Bonthu N; Batra SK
    J Clin Pathol; 2010 Jul; 63(7):579-84. PubMed ID: 20591909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
    Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
    Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
    Alomari AK; Glusac EJ; McNiff JM
    J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.
    Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW
    J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature.
    Mejbel HA; Nelson KC; Pradhan D; Ivan D; Zaleski M; Nagarajan P; Tetzlaff MT; Curry JL; Torres-Cabala CA; Prieto VG; Aung PP
    J Cutan Pathol; 2020 Jan; 47(1):36-46. PubMed ID: 31361351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved.
    Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S
    Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
    Bakry OA; Samaka RM; Shoeib MA; Megahed DM
    Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
    Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
    Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
    Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognising the signs of skin cancer.
    Godsell G
    Nurs Times; 2003 Aug 5-11; 99(31):44-5. PubMed ID: 13677122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of spexin and DARS2 as potential biomarkers in basal cell carcinoma and cutaneous malignant melanoma diagnosis, and as therapeutic targets.
    Erdoğan MM; Yerlikaya Kavak S
    Arch Dermatol Res; 2024 Oct; 316(10):698. PubMed ID: 39417889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible Usage of p63 in Bioptic Diagnostics.
    Galoczová M; Nenutil R; Coates P; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p40 in Conjunction With CK20 and E-Cadherin Distinguishes Primary Adnexal Neoplasms of the Skin.
    Andruszkow JH; Oll M; Förster S; Knüchel R; Jäkel J
    Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):414-21. PubMed ID: 26180934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common skin cancers.
    Lee PK
    Minn Med; 2004 Mar; 87(3):44-7. PubMed ID: 15080294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal.
    Webb DV; Mentrikoski MJ; Verduin L; Brill LB; Wick MR
    Ann Diagn Pathol; 2015 Apr; 19(2):70-5. PubMed ID: 25702956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.